NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

Clutch Size

Measurement of cell-me

Somatosensory Disorder

Facilitation of a Mult

NPM and BRG1 Mediate T

See All (7) pages

Contact Us
If you have any questions or feedback please contact us.

NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.

Nichol JN, Galbraith MD, Kleinman CL, Espinosa JM, Miller WH. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia. Cell Rep. 2016 Mar 29; 14(12):2938-49.

View in: PubMed

subject areas

CCAAT-Enhancer-Binding Protein-beta
Cell Differentiation
Cell Line, Tumor
Chromatin Assembly and Disassembly
Chromatin Immunoprecipitation
DNA Helicases
DNA Topoisomerases, Type II
DNA-Binding Proteins
Drug Resistance, Neoplasm
Humans
Leukemia, Promyelocytic, Acute
Nuclear Proteins
Poly-ADP-Ribose Binding Proteins
Promoter Regions, Genetic
Promyelocytic Leukemia Protein
Real-Time Polymerase Chain Reaction
Retinoic Acid Receptor alpha
RNA Interference
RNA, Small Interfering
Transcription Factors
Transcriptional Activation
Tretinoin

authors with profiles

Matthew Dominic Galbraith

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium